E-prescription advocates in Oregon may have successfully lobbied for the reintroduction of legislature that would lift the ban on e-prescriptions for Schedule II drugs, according to a Statesman Journal report.
H.B. 3522, a bill introduced last year but stalled in committee, would allow e-prescriptions for medications like Oxycotin and Adderall in non-emergent situations. Advocates of the bill, including representatives from the Oregon Pharmacy Coalition and the Oregon Board of Pharmacy, lobbied for the bill's reintroduction in February 2014, according to the report.
The bill's advocates may have found an ally in Rep. Mitch Greenlick (D-Portland), chairman of the House Interim Committee on Health Care, who said he will ensure the legislation is considered.
More Articles on e-Prescriptions:
Where is EHR and E-Prescribing Adoption the Highest? In the Upper Midwest.
E-Prescribing Market to Hit $794M by 2017
Rhode Island Passes Legislation to Facilitate e-Prescribing